BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18509652)

  • 1. Leukocytapheresis for the treatment of refractory Henoch-Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy.
    Oki E; Tsugawa K; Suzuki K; Ito E; Tanaka H
    Rheumatol Int; 2008 Sep; 28(11):1181-2. PubMed ID: 18509652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytapheresis for the treatment of refractory Henoch-Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy.
    Oki E; Tsugawa K; Suzuki K; Ito E; Tanaka H
    Rheumatol Int; 2008 Jun; 28(8):823-4. PubMed ID: 18335220
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with leukocytapheresis in refractory Henoch-Schönlein purpura: case report.
    Nakahata T; Tanaka H; Suzuki K; Ito E
    Clin Rheumatol; 2003 Sep; 22(3):248-50. PubMed ID: 14505222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of hemorrhagic bullous Henoch-Schonlein purpura with intravenous immunoglobulins.
    Mauro A; Mauro S; Rega R; Martemucci L; Sottile R
    Pediatr Dermatol; 2019 Jan; 36(1):e34-e36. PubMed ID: 30561101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methylprednisolone pulse therapy for treatment of refractory intestinal involvement caused by Henoch-Schönlein purpura: a case report.
    Kang HS; Chung HS; Kang KS; Han KH
    J Med Case Rep; 2015 Mar; 9():65. PubMed ID: 25885905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in Henoch-Schönlein purpura: a case study.
    Heldrich FJ; Minkin S; Gatdula CL
    Md Med J; 1993 Jun; 42(6):577-9. PubMed ID: 8377631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery thickening with mucosal lesions in Henoch-Schönlein purpura.
    Veetil BM; Reed AM; Mattke AC
    Pediatr Dermatol; 2012; 29(3):377-8. PubMed ID: 21906140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Henoch-Schönlein purpura (treatment and outcome).
    Dillon MJ
    Cleve Clin J Med; 2002; 69 Suppl 2():SII121-3. PubMed ID: 12086251
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchange therapy for severe gastrointestinal involvement of Henoch Schönlein purpura in children.
    Başaran Ö; Cakar N; Uncu N; Çelikel BA; Kara A; Cayci FS; Taktak A; Gür G
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-176-80. PubMed ID: 25436762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Henoch-Schönlein purpura - one of the most common types of systemic vasculitis in childhood].
    Sileikiene R; Tamakauskiene E; Baksiene D
    Medicina (Kaunas); 2003; 39(5):476-9. PubMed ID: 12794371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins.
    Kusuda A; Migita K; Tsuboi M; Degawa M; Matsuoka N; Tominaga M; Kawakami A; Kawabe Y; Taguchi T; Eguchi K
    Intern Med; 1999 Apr; 38(4):376-9. PubMed ID: 10361914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schönlein purpura: worth a controlled trial against corticosteroids?
    Morotti F; Bracciolini G; Caorsi R; Cattaneo L; Gattorno M; Ravelli A; Felici E
    Rheumatology (Oxford); 2021 Aug; 60(8):3868-3871. PubMed ID: 34340243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive meningococcal disease presenting as Henoch-Schonlein purpura.
    Tsolia MN; Fretzayas A; Georgouli H; Tzanakaki G; Fessatou S; Liapi-Adamidou G; Constantopoulos A
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):776-9. PubMed ID: 15605185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in Henoch-Schönlein purpura.
    Hamidou MA; Pottier MA; Dupas B
    Ann Intern Med; 1996 Dec; 125(12):1013-4. PubMed ID: 8967701
    [No Abstract]   [Full Text] [Related]  

  • 15. A girl with Henoch Schönlein purpura associated with acute rheumatic fever and review of literature.
    Aypar E; Demirtaş D; Aykan HH; Kara-Eroğlu F; Düzova A
    Turk J Pediatr; 2018; 60(5):576-580. PubMed ID: 30968630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
    Crayne CB; Eloseily E; Mannion ML; Azerf SP; Weiser P; Beukelman T; Stoll ML; Feig DI; Prescott Atkinson T; Cron RQ
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):71. PubMed ID: 30428889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic bullous lesions in Henoch-Schönlein purpura: a case report and review of the literature.
    Su HW; Chen CY; Chiou YH
    BMC Pediatr; 2018 May; 18(1):157. PubMed ID: 29747613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Henoch-Schonlein purpura presenting duodenal involvement similar to superior mesenteric artery syndrome in a girl.
    Harada T; Machida H; Ito S; Aihara Y; Yokota S
    Eur J Pediatr; 2007 May; 166(5):489-90. PubMed ID: 17009000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Henoch-Schonlein Purpura with dilated coronary arteries.
    Bloom JL; Darst JR; Prok L; Soep JB
    Pediatr Rheumatol Online J; 2018 Sep; 16(1):54. PubMed ID: 30180850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Henoch-Schönlein purpura in a patient with Behçet's disease presenting with recurrent deep vein thrombosis.
    Park YW; Park JJ; Lee JB; Lee SS
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S96-8. PubMed ID: 17949560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.